Results 171 to 180 of about 216,413 (307)

PLEIOTROPIC EFFECTS OF STATINS

Медицина в Кузбассе
Statins are among the most widely prescribed medications worldwide and are known for their hypolipidemic effects. However, in recent years more and more data have been accumulated regarding the beneficial effects of statins, beyond lowering the ...
Татьяна Евгеньевна Помыткина, Полина Анатольевна Линсцер, Эдуард Александрович Драганов   +2 more
doaj  

High-intensity hydrophilic versus lipophilic statins in patients with primary biliary cholangitis: a multi-institutional analysis. [PDF]

BMC Gastroenterol
Kawas H, Alabbas M, Abu-Hammour MN, Eren B, Hazem W, Sims OT, Chiang DJ.   +6 more
europepmc   +1 more source

Stopping Statins [PDF]

Circulation, 2004
openaire   +2 more sources

Inflammation, Immunity, and Cardiovascular Diseases

Med Research, EarlyView.
Cardiovascular stress signals (e.g., hemodynamic shear, oxidized lipids, and ischemia) act on endothelial and immune cells to activate and amplify inflammation through NF‐κB, the NLRP3 inflammasome, and JAK/STAT signaling, inducing proinflammatory cytokines/chemokines (IL‐6, IL‐1β, TNF‐α, and CCL2) and self‐amplifying circuits; clinically, inflammatory
Dezhi Guo, Yan Liao, Rui Zhao, Zhaoyu Li, Kaikai Wang, Haoling Zhang, Pingxin Sun, Yadong Guo, Wangzheqi Zhang   +8 more
wiley   +1 more source

Trends and inequalities in statin use for the primary and secondary prevention of cardiovascular disease between 2009 and 2021 in England: a series of cross-sectional and cohort studies. [PDF]

BMJ Public Health
Muzambi R, Bhaskaran K, Strongman H, van Staa T, Smeeth L, Suffel AM, Herrett E.   +6 more
europepmc   +1 more source

Small Strokes, Big Impact: Excessive Mortality After Acute Ischemic Stroke in Parkinson's Disease

Movement Disorders, EarlyView.
Abstract Background Acute ischemic stroke (AIS) in those with Parkinson's disease (PD) is a growing healthcare burden but mortality studies are significantly lacking. Objective To map short‐ and long‐term survival, stratified by relevant comorbidities and stroke characteristics.
Lee E. Neilson, Chen Lin, Anusha Mishra, Gregory D. Scott   +3 more
wiley   +1 more source

Prescribing statins [PDF]

British Journal of Clinical Pharmacology, 2005
openaire   +1 more source

Elevation of Stearoyl‐Coenzyme A Desaturase and Monounsaturated Fatty Acids in Parkinson's Disease Serum

Movement Disorders, EarlyView.
Abstract Background Emerging evidence indicates that dysregulation of monounsaturated fatty acids (MUFAs), synthesized by the enzyme stearoyl‐coenzyme A desaturase (SCD), impacts on α‐synuclein pathology in the Parkinson's disease (PD) brain. Objective The objective of this study was to analyze SCD and MUFA‐enriched lipids in the periphery of patients ...
Finula I. Isik, Russell Pickford, Michelle Chua, Simon J.G. Lewis, Nicolas Dzamko, Woojin Scott Kim   +5 more
wiley   +1 more source

Revisiting the Association Between Calcium Channel Blockers and Parkinson's Disease in the E3N Cohort

Movement Disorders, EarlyView.
Abstract Background Previous studies on calcium channel blockers (CCBs) and Parkinson's disease (PD) risk reached conflicting conclusions. Objectives We examined the relationship between CCBs and PD in the E3N cohort of French women followed for 15 years (2004–2018), while taking into account the potential for reverse causation.
Emilie Moutard, Agnès Fournier, Émeline Courtois, Fanny Artaud, Pascale Tubert‐Bitter, Emmanuel Roze, Ismaïl Ahmed, Anne C.M. Thiébaut, Alexis Elbaz, Thi Thu Ha Nguyen   +9 more
wiley   +1 more source

Risk of new-onset diabetes across individual statins in secondary prevention: results from the Korean national health insurance service cohort. [PDF]

Front Cardiovasc Med
Park EJ, Park Y, Kang DO, Park S, Roh SY, Na JO, Kim JW, Kim EJ, Rha SW, Park CG, Choi CU.   +10 more
europepmc   +1 more source